Robert Azelby Insider Trading $CASC Cascadian Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Robert Azelby.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Robert Azelby. Robert Azelby is Director in IMMUNOMEDICS INC ($IMMU) and Director in Cascadian Therapeutics, Inc. ($CASC) and President and CEO in ALDER BIOPHARMACEUTICALS INC ($ALDR) and Director in Clovis Oncology, Inc. ($CLVS) and EVP & Chief Commercial Officer in Juno Therapeutics, Inc. ($JUNO) and See Remarks in Juno Therapeutics, Inc. ($JUNO).

Robert Azelby in Cascadian Therapeutics, Inc.

Trading Symbol: CASC
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Robert Azelby: Director
Holdings: 0 shares
Latest Transaction: Mar 13 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Robert Azelby in Cascadian Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ALDR, CASC, CLVS, IMMU, JUNO

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 13 2018CASCCascadian Therapeu ...Azelby RobertDirectorOption ExerciseD0.0013,92700
Mar 13 2018CASCCascadian Therapeu ...Azelby RobertDirectorOption ExerciseD0.0012,43700
Jun 13 2017CASCCascadian Therapeu ...Azelby RobertDirectorOption ExerciseA0.0013,927013,927
Apr 04 2017CASCCascadian Therapeu ...Azelby RobertDirectorOption ExerciseA0.0012,437012,437

Page:   1